Literature DB >> 10327420

Cytochrome-c oxidase isolated from the brain of swayback-diseased sheep displays unusual structure and uncharacteristic kinetics.

T Alleyne1, J Joseph, A Lalla, V Sampson, A Adogwa.   

Abstract

Swayback disease, a neurodegenerative disorder of lambs, and Menkes disease, the human equivalent, are caused by a deficiency of dietary copper. Reports of low enzymic activity suggest that several copper-containing enzymes, including cytochrome-c oxidase (COX), may influence the progress of these diseases. To investigate its role in the development of neurodegenerative disorders, in particular swayback disease, we isolated COX from the brains and livers of swayback-diseased lambs. Comparative sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) combined with densitometric analysis revealed that whereas the structure of COX from the liver of diseased animals was normal, the corresponding brain enzyme was subunits II-, III-, and IV-deficient; the deficiency was 55, 30, and 65% respectively. The activities of liver and brain COX from normal and diseased lambs were compared by polarographic assay at low ionic strength. Whereas the enzyme from normal brains and both forms of the liver enzyme yielded characteristic biphasic Eadie-Hofstee plots, the brain enzyme from diseased animals displayed a single phase with a K(m) of 4.7 +/- 2.4 x 10(-6) M: the K(m) values of COX from the normal brain were 12 +/- 2.5 x 10(-6) and 5.5 +/- 0.5 x 10(-7) M. We conclude that the altered enzyme structure accounts for the uncharacteristic kinetics and low activity we have observed for the isolated brain enzyme. We also conclude that the altered enzyme structure partly accounts for the low oxidase activity and decreased ATP synthesis that has been widely reported for brain tissue from swayback-diseased animals. We postulate that the subunit deficiency probably results from incomplete crosslinking between the subunits and the membrane, and predict that similar structural and kinetic factors may also account for low COX activity in Menkes disease.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 10327420     DOI: 10.1007/bf02815082

Source DB:  PubMed          Journal:  Mol Chem Neuropathol        ISSN: 1044-7393


  5 in total

1.  Unraveling the role of metal ions and low catalytic activity of cytochrome C oxidase in Alzheimer's disease.

Authors:  Trevor Alleyne; Neetu Mohan; Jerome Joseph; Andrew Adogwa
Journal:  J Mol Neurosci       Date:  2010-08-20       Impact factor: 3.444

2.  The role of Thr5 in human neuron growth inhibitory factor.

Authors:  Bin Cai; Qi Zheng; Xin-Chen Teng; Dong Chen; Yang Wang; Ke-Qiang Wang; Guo-Ming Zhou; Yi Xie; Ming-Jie Zhang; Hong-Zhe Sun; Zhong-Xian Huang
Journal:  J Biol Inorg Chem       Date:  2006-04-07       Impact factor: 3.358

3.  Imaging features of copper deficiency myelopathy: a study of 25 cases.

Authors:  Neeraj Kumar; J Eric Ahlskog; Christopher J Klein; John D Port
Journal:  Neuroradiology       Date:  2005-10-28       Impact factor: 2.804

4.  Sheep have an unusual variant of the brain-specific metallothionein, metallothionein-III.

Authors:  Roger S Chung; Adele F Holloway; Bedrich L Eckhardt; Julie A Harris; James C Vickers; Meng Inn Chuah; Adrian K West
Journal:  Biochem J       Date:  2002-07-01       Impact factor: 3.857

5.  Low activity and poor membrane tethering for rabbit brain cytochrome C oxidase in cholesterol-copper Alzheimer's model.

Authors:  Neetu Mohan; Trevor Alleyne; Jerome Joseph; Andrew Adogwa
Journal:  J Mol Neurosci       Date:  2009-05-22       Impact factor: 3.444

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.